ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,669Medicare Part D Prescriptions Filled, Including Refills

Rank: 140 out of 2888

$938K Total Retail Price of All Prescriptions

Rank: 246 out of 2888

495 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

20% of this provider’s 495 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 13,786 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
FUROSEMIDE 704 547 1 6
POTASSIUM CHLORIDE 648 556 2 14
SIMVASTATIN 647 539 3 2
LEVOTHYROXINE SODIUM 641 525 4 1
OMEPRAZOLE 506 425 5 7
METFORMIN HCL 492 372 6 8
HYDROCODONE-ACETAMINOPHEN 486 344 S3 7 4
PRAVASTATIN SODIUM 402 288 8 12
LISINOPRIL 380 328 9 3
AMLODIPINE BESYLATE 364 316 10 5
GLIMEPIRIDE 324 197 11 36
GABAPENTIN 292 212 12 13
METOPROLOL SUCCINATE 287 247 13 11
TRAMADOL HCL 274 216 14 16
ALENDRONATE SODIUM 260 201 15 23
WARFARIN SODIUM 251 222 16 22
CITALOPRAM HBR 237 186 17 24
DONEPEZIL HCL 229 216 18 26
ATENOLOL 205 169 19 25
ATORVASTATIN CALCIUM 191 151 20 9
ZOLPIDEM TARTRATE 184 158 21 17
METOPROLOL TARTRATE 180 164 22 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 179 132 23 28
MELOXICAM 175 143 24 31
LOSARTAN POTASSIUM 169 160 25 18
CLOPIDOGREL 158 133 26 30
AZITHROMYCIN 151 114 27 38
ISOSORBIDE MONONITRATE ER 147 139 28 51
TRIAMTERENE-HCTZ 141 117 29 63
NEXIUM 137 99 30 19
CARVEDILOL 130 119 31 21
RAMIPRIL 128 92 32 73
QUETIAPINE FUMARATE 124 115 33 66
NAMENDA 122 115 34 34
RANITIDINE HCL 122 81 34 56
SERTRALINE HCL 121 100 36 27
HYDROCHLOROTHIAZIDE 112 90 37 15
PLAVIX 109 90 38 40
ENALAPRIL MALEATE 108 85 39 49
ADVAIR DISKUS 105 77 40 60
CYMBALTA 104 73 41 44
DIGOXIN 104 104 41 55
ESCITALOPRAM OXALATE 103 92 43 62
LOSARTAN-HYDROCHLOROTHIAZIDE 102 67 44 46
ALLOPURINOL 102 65 44 37
LYRICA 95 57 46 69
JANUVIA 95 83 46 48
ROPINIROLE HCL 93 85 48 115
LOVASTATIN 91 87 49 41
SEROQUEL 88 73 50 143
PANTOPRAZOLE SODIUM 88 72 50 33
VENLAFAXINE HCL ER 84 54 52 120
TAMSULOSIN HCL 83 71 53 29
CYCLOBENZAPRINE HCL 76 36 R 54 68
LANTUS 76 47 54 45
KLOR-CON M20 73 53 56 90
PHENYTOIN SODIUM EXTENDED 73 73 56 128
TRIAMTERENE-HYDROCHLOROTHIAZID 71 60 58 259
DOXAZOSIN MESYLATE 70 40 59 94
PAROXETINE HCL 69 56 60 84
CLONIDINE HCL 66 54 61 39
MIRTAZAPINE 65 60 62 54
METOCLOPRAMIDE HCL 65 52 62 116
LIPITOR 64 61 64 78
POLYETHYLENE GLYCOL 3350 64 41 64 93
PROMETHAZINE HCL 63 20 R 66 96
RISPERIDONE 63 22 66 72
AMITRIPTYLINE HCL 60 39 R 68 74
CIPROFLOXACIN HCL 59 40 69 47
EVISTA 58 58 70 125
FLUTICASONE PROPIONATE 58 44 70 32
VERAPAMIL ER 57 40 72 104
CRESTOR 57 48 72 20
SPIRIVA 55 44 74 79
TRICOR 55 29 74 91
FLUOXETINE HCL 55 39 74 83
FINASTERIDE 55 47 74 102
LEVOFLOXACIN 54 41 78 57
LEVETIRACETAM 53 21 79 103
KLOR-CON M10 53 40 79 118
BACLOFEN 52 20 81 121
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 32 81 88
HALOPERIDOL 51 26 83 282
PROAIR HFA 50 36 84 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 30, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.